Gilead Sciences

GILD

GILD
Gilead Sciences Stock Quote
$66.78 -$0.39 -0.6%
BATS BZX Real Time Price as of May 24, 2019, 2:29 p.m. View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

News & Analysis: Gilead Sciences

The Fool has written over 1400 articles on Gilead Sciences.

All

Market Moves

Podcasts

Earnings

3 Top Biotech Stocks to Buy Right Now

These three biotech stocks should turn out to be outstanding long-term growth vehicles.











Interactive Chart